Jens Hennecke

Chief Business Officer
Pharmaceutical Sciences
Sotio
Czech Republic

Business Expert Pharmaceutical Sciences
Biography

Jens Hennecke is an Chief Business Officer Working at Sotio is a biotechnology company developing a new Active Cellular Immunotherapy (“ACI”) based on activated dendritic cells for the treatment of cancer and autoimmune diseases. SOTIO continues to develop new therapies to address unmet medical needs using its immunotherapy platform and proprietary cell-based technologies.

Research Intrest

Pharmaceutical Industry, GMP, Quality Control, Pharmaceutical Manufacturing,Clinical Trails ,Clinical Research

Global Scientific Words in Pharmaceutical Sciences